NDC 83114-001
MIFEPRISTONE
Mifepristone
MIFEPRISTONE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pci Pharma Services Canada, Inc.. The primary component is Mifepristone.
| Product ID | 83114-001_ed8c0b7a-2dac-2bb1-e053-2a95a90aa156 |
| NDC | 83114-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | MIFEPRISTONE |
| Generic Name | Mifepristone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-11 |
| Marketing Category | ANDA / |
| Application Number | ANDA091178 |
| Labeler Name | PCI Pharma Services Canada, Inc. |
| Substance Name | MIFEPRISTONE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Progestational Hormone Receptor Antagonists [MoA], Progestin Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |